A Peek at Amneal Pharmaceuticals's Future Earnings

Amneal Pharmaceuticals AMRX is gearing up to announce its quarterly earnings on Tuesday, 2025-08-05. Here's a quick overview of what investors should know before the release.

Analysts are estimating that Amneal Pharmaceuticals will report an earnings per share (EPS) of $0.17.

Amneal Pharmaceuticals bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Past Earnings Performance

The company's EPS beat by $0.06 in the last quarter, leading to a 0.0% drop in the share price on the following day.

Here's a look at Amneal Pharmaceuticals's past performance and the resulting price change:

Stock Performance

Shares of Amneal Pharmaceuticals were trading at $7.83 as of August 01. Over the last 52-week period, shares are up 13.52%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release.

To track all earnings releases for Amneal Pharmaceuticals visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.